Download Unicorn Signals App

By EquityPandit

Latest News

Zydus subsidiary gets USFDA approval to market Tamiflu drug

Zydus Cadila‘s US subsidiary has got the approval from the US health regulator for marketing oseltamivir phosphate capsules that are used in treating Tamiflu.

Cadila Healthcare has said in a BSE filing that “Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the United States Food and Drug Administration (USFDA) for marketing oseltamivir phosphate capsules in strengths of 30 mg, 45 mg, and 75 mg.”

The company, quoting IMS December 2016 sales data said oseltamivir phosphate capsules had sales worth USD 382 million.

Read EquityPandit’s Technical Analysis on Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
Latest
IPO
Weekly
Outlook

Stock
Market
Prediction